Andrea Lobo

At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.

Articles by Andrea Lobo

MYELOMA

Abecma OK’d in US to take earlier in treatments for multiple myeloma

The U.S. Food and Drug Administration (FDA) has expanded the indication of Abecma (idecabtagene vicleucel) to allow its use…

MYELOMA

CAR T-cell therapy recommended as earlier treatment line for RRMM

An advisory committee of the U.S. Food and Drug Administration (FDA) has unanimously recommended extending the approval of Janssen’s…

MYELOMA

Phase 1b trial of STAR-LLD combo for myeloma approved by FDA

The U.S. Food and Drug Administration (FDA) has cleared the launch of a Phase 1b trial to test STAR-LLD,…